Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.22.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2019 $ (6,952,851) $ 135,989 $ 35,918,827 $ (20,563,357) $ (22,444,310)
Beginning balance, shares at Nov. 30, 2019   13,598,909      
Exercise of stock options 41,000 $ 347 40,653    
Exercise of stock options, shares   34,729      
Compensatory element of stock options 622,120   622,120    
Net income 3,624,596       3,624,596
Ending balance at Nov. 30, 2020 (2,665,135) $ 136,336 36,581,600 (20,563,357) (18,819,714)
Ending balance, shares at Nov. 30, 2020   13,633,638      
Exercise of stock options 1,128,517 $ 6,224 1,122,293    
Exercise of stock options, shares   622,400      
Common stock issued to Duke 3,585,172 $ 4,098 3,581,074    
Common stock issued to Duke, shares   409,734      
Compensatory element of stock options 301,616   301,616    
Treasury stock (249,377)     (249,377)  
Net income 2,083,521       2,083,521
Ending balance at Nov. 30, 2021 $ 4,184,314 $ 146,658 $ 41,586,583 $ (20,812,734) $ (16,736,193)
Ending balance, shares at Nov. 30, 2021   14,665,772